Los Angeles, CANCT06039501Now EnrollingIRB Ready

Respiratory Failure Clinical Trial in Los Angeles, CA

Access cutting-edge respiratory failure treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by Matthew Modes

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access respiratory failure specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related respiratory failure treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this respiratory failure clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Respiratory Failure Study in Los Angeles

The purpose of the study is to conduct a pilot randomized trial of a program designed to enhance equitable communication and emotional support for families of critically ill patients in order to determine feasibility, acceptability, and participant experience with the program. The primary study procedures include: chart abstraction, questionnaires, meetings with ICU support counselors, meetings with ICU physicians and care team, audio recordings of these meetings (optional), and interviews with study participants (optional). Study participants include: 70 critically ill patients with acute respiratory failure (enrolled with the consent of their Legally Authorized Representative) and their primary surrogate decision makers as well as ICU support counselors and ICU care teams (physicians, nurses, social workers).

Sponsor: Matthew Modes

Who Can Participate

Inclusion Criteria

Patient inclusion criteria:
Individuals 18 years old or older.
Individuals admitted to the medical intensive care unit (MICU) at Cedars-Sinai Medical Center.
Individuals with acute respiratory failure, defined as \>24 hours of invasive mechanical ventilation.
Individuals who received invasive mechanical ventilation within 24 hours of admission to the MICU.
Individuals expected to need invasive mechanical ventilation for \>72 hours total, as determined by the patient's intensivist physician (fellow or attending).
Primary surrogate decision maker inclusion criteria: o Individuals 18 years old or older.
Individual who self-identifies as the most responsible for making decisions for the enrolled patient (can be either family member or close friend).
Proficiency in English language.
ICU support counselor inclusion criteria:
Individuals 18 years old or older.
Individuals who work as hospital chaplains in the MICU.
Physician (intensivist) inclusion criteria:
Individuals 18 years old or older.
Individuals who work as critical care physicians in the MICU (fellow or attending).
Nurse inclusion criteria:
Individuals 18 years old or older.
Individuals who work as bedside nurses in the MICU.
Social worker inclusion criteria:
Individuals 18 years old or older.
Individuals work as social workers in the MICU.

Exclusion Criteria

Patient exclusion criteria: o Any records flagged "break the glass" or "research opt out." o Individuals expected to die within 24 hours of potential enrollment, as determined by the patient's intensivist physician (fellow or attending). o Individuals on comfort care protocol or with clear preference for comfort care, as determined by the patient's intensivist physician (fellow or attending).
Individuals who are chronically dependent on a ventilator prior to admission.
Individuals with acute on chronic neuromuscular disease-related respiratory failure (e.g., Guillain Barre, Muscular Dystrophy, Myasthenia Gravis, etc.).
Individuals imminently awaiting organ transplant, as determined by the patient's intensivist physician (fellow or attending).
Individuals with decisional capacity, as determined by the patient's intensivist physician (fellow or attending).
Individuals who are unrepresented (i.e., patient has no surrogate decision maker).
Individuals whose potential enrolled family member (primary surrogate decision maker) is not proficient in English.
Individuals whose attending physician is the PI on this study at the time of potential enrollment.
Individuals who are cared for by intensivist physicians (fellow and attending) who do not agree to participate in the study.
Individuals who have a pre-existing relationship with a hospital chaplain who does not agree to participate in the study, as determined by that chaplain.
Primary surrogate decision maker exclusion criteria: o Not proficient in English language. (Rationale: materials and intervention are not adapted in other languages.)
ICU support counselor exclusion criteria: o None
Physician (intensivist) exclusion criteria: o None
Nurse exclusion criteria: o None
Social worker exclusion criteria:

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT06039501) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Respiratory Failure Treatment Options in Los Angeles, CA

If you're searching for respiratory failure treatment options in Los Angeles, CA, this clinical trial (NCT06039501) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced respiratory failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all respiratory failure clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Los Angeles, CA

See all rheumatoid arthritis clinical trials recruiting in Los Angeles — not just this study.

Browse Rheumatoid Arthritis Trials in Los Angeles →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsFanconi Anemia TrialsAll Conditions →

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA